Open AccessPhase 1b dose-escalation, safety, and pharmacokinetic study of IC14, a monoclonal antibody against CD14, for the treatment of amyotrophic lateral sclerosis
Author(s) -
Robert D. Henderson,
Jan M. Agosti,
Pamela McCombe,
Kathryn A Thorpe,
Susan Heggie,
Saman Heshmat,
Mark W. Appleby,
B. Ziegelaar,
David T Crowe,
Garry Redlich
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000027421
Subject(s) - medicine , amyotrophic lateral sclerosis , tolerability , adverse effect , gastroenterology , pharmacodynamics , pharmacokinetics , pharmacology , disease